Evaluation of patient enrollment in oncology phase I clinical trials.

Introduction: For anticancer drug development, it is crucial that patients participate in early-phase clinical trials. The main aim of this study was to gain insight into the motivations and other variables influencing patients in their decision to participate in phase I oncology trials.

Materials And Methods: Over a period of 25 months, all patients who were informed about (specific) phase I trials in our cancer center were retrospectively included in this study.